How the Delta variant differs from previous mutations

Dr. Ashish Jha, the dean of Brown University School of Public Health, discusses how symptoms of the emerging variant, which has been called “COVID on steroids,” might be different than other strains.
2:45 | 06/17/21

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for How the Delta variant differs from previous mutations
Let's bring in Dr. Ashish jha Dean of the brown university school of public health. Covid on steroids. That's how a former white house adviser puts it. You might not have used those words. Do you agree with the sentiment? Good morning. Thanks for having me back. I certainly agree it's the most contagious variant we've seen throughout the pandemic. It's probably the most challenging variant overall. I don't know if I would use exactly those words. I would definitely say this is a challenge we have to deal with. You say a challenge. Part of that challenge is that the symptoms for the delta variant seem to be different. Why is that concerning and what are those symptoms that people need to be aware of? Across all the variants, it's the same underlying virus. The major symptoms are fever, cough, headache, shortness of breath, sometimes loss of smell and taste. We've seen preliminary evidence maybe more headaches with this. We've got to sort it out. If you're having any symptoms, you need to get tested. More and more people are being vaccinated. Communities and states are being opened up. We're trying to look forward. We're still looking back and trying to figure out where this coronavirus came from. Why is that still so important that we understand and learn whether it came from nature or came from a lab? Where do you come down seeing more and more names coming out that they're open to the idea it was produced in a lab? It's the worst pandemic we've had in a century. We have to know where it came from. That will change how we prevent future pandemics. None of us know whether it started in a lab or came from nature. It's worth figuring out. It's essential we figure it out. I don't have a personal theory myself. I'm open to various theories. We've got to get to the bottom of it. This myocarditis showing up in younger folks. CDC advisory panel meeting to discuss this. What do we expect to come out of this? How concerning are the numbers now in younger folks? We've had millions and millions of people in this age range 16-30 who got vaccinated. A tiny fraction seem to have this heart inflammation. We want to be careful and make sure if it's caused by the vaccine we sort that out. I've gotten my teenage children vaccinated. The benefits of vaccinations outweigh the risks. Dr. Jha, thanks so much. Robin? Now to that new development on the high seas.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"2:45","description":"Dr. Ashish Jha, the dean of Brown University School of Public Health, discusses how symptoms of the emerging variant, which has been called “COVID on steroids,” might be different than other strains.","mediaType":"default","section":"ABCNews/GMA","id":"78332213","title":"How the Delta variant differs from previous mutations","url":"/GMA/News/video/delta-variant-differs-previous-mutations-78332213"}